Reuters - Health Report

Click to View in Browser

Monday, September 4, 2017

Novartis's Jimenez stepping down, Narasimhan named new CEO

ZURICH (Reuters) - Novartis Chief Executive Joseph Jimenez will retire in 2018, with chief drug developer Vasant Narasimhan taking over as CEO starting in February, the Swiss drugmaker said on Monday.

Anthem cuts back Obamacare coverage in Missouri to 68 counties

NEW YORK (Reuters) - U.S. health insurer Anthem Inc said on Friday that it will no longer offer Obamacare plans in 17 counties in Missouri but will remain in the bulk of the state, covering 68 counties that would not otherwise have Obamacare coverage for their residents.

FDA approves Pfizer's leukemia drug

(Reuters) - The U.S. Food and Drug Administration (FDA) on Friday approved Pfizer Inc's drug, Mylotarg, for certain patients with acute myeloid leukemia (AML), re-clearing a drug that had been pulled off the market in 2010.

Advertising budget for Obamacare to be cut 90 percent: U.S. health agency

WASHINGTON (Reuters) - The U.S. Centers for Medicare and Medicaid Services said on Thursday it plans to spend $10 million on advertising for the upcoming Obamacare open enrollment period that starts in November, a sharp cut from the $100 million spent last year.

Arizona accuses drugmaker Insys of fraudulent opioid marketing

(Reuters) - Arizona sued Insys Therapeutics Inc on Thursday, accusing the drugmaker of engaging in a fraudulent marketing scheme aimed at increasing sales of a fentanyl-based cancer pain medicine called Subsys.

Parents of mentally ill teens aren't more likely to store guns safely

(Reuters Health) - Parents of adolescents with depression or bipolar disorder are no more likely than households without a mentally ill teen to follow safe firearm storage practices, a recent U.S. study suggests.

Childhood cancer survivors may face decades of high medical costs

(Reuters Health) - Childhood cancer survivors may face steep out-of-pocket medical expenses well into adulthood, a recent U.S. study suggests.

Parents find older babies sleep better in their own room

(Reuters Health) - Parents who put babies to sleep in their own rooms report the infants get more rest and have more consistent bedtime routines than parents who share a room or a bed with their babies, a recent study suggests.

Amazon hit with lawsuit over eclipse glasses

NEW YORK (Reuters) - Amazon.com has been hit with a proposed class action lawsuit by a couple who claims defective eclipse glasses purchased through the online retailer damaged their eyes.

AstraZeneca aims to offset drug setback at big cancer congress

LONDON (Reuters) - After last month's big clinical trial setback in lung cancer, AstraZeneca will seek to rebuild its oncology reputation next week when it unveils full details of two key clinical trials tackling the disease in different ways.